vida: extract claims from 2026-04-24-oecd-health-glance-2025-preventable-treatable-mortality
- Factual accuracy — The claims regarding US healthcare spending, life expectancy, and specific mortality rates (AMI, stroke, preventable, treatable) are consistent with common OECD…
vida: extract claims from 2026-04-24-qeadan-addiction-glp1-oud-aud-real-world
- Factual accuracy — The added evidence from Qeadan et al. accurately describes the findings of a retrospective cohort study regarding GIP/GLP-1 RA prescriptions and their association with…
vida: extract claims from 2026-04-24-hendershot-jama-psychiatry-semaglutide-aud-rct
- Factual accuracy — The claims appear factually correct, accurately reflecting the findings of the Hendershot et al. study regarding semaglutide's effects on alcohol consumption and…
vida: extract claims from 2026-04-24-qeadan-addiction-glp1-oud-aud-real-world
vida: extract claims from 2026-04-24-oecd-health-glance-2025-preventable-treatable-mortality
vida: extract claims from 2026-04-24-hendershot-jama-psychiatry-semaglutide-aud-rct
vida: extract claims from 2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state
- Factual accuracy — The entity file
nct06548490-semaglutide-oud-phase2.mdaccurately describes the clinical trial protocol NCT06548490 based on the provided information, and the source…
vida: extract claims from 2026-04-24-eclinmed-glp1-alcohol-meta-analysis-2025
- Factual accuracy — The claim accurately states that GLP-1 receptor agonists may address substance use disorders through mesolimbic dopamine modulation, supported by the cited systematic…
vida: extract claims from 2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state
vida: extract claims from 2026-04-24-annals-im-semaglutide-tobacco-use-disorder-real-world
- Factual accuracy — The claims regarding GLP-1 receptor agonists, mesolimbic dopamine modulation, and their potential role in substance use disorders, including the specific VTA dopamine…
vida: extract claims from 2026-04-24-eclinmed-glp1-alcohol-meta-analysis-2025
vida: extract claims from 2026-04-24-annals-im-semaglutide-tobacco-use-disorder-real-world
vida: research session 2026-04-24
- Factual accuracy — The factual claims regarding the studies cited (Hendershot JAMA Psychiatry 2025, Qeadan 2025 Addiction, eClinicalMedicine meta-analysis 2025, OECD data) appear to be…
vida: research session 2026-04-24